In this podcast episode, McCall McPherson explores the complexities of Graves' disease and hypothyroidism
Contact us or book an appointment online to discuss the most suitable weight-loss strategy for you
The relationship between GLP-1 receptor agonists and eye problems is complex and requires careful interpretation of available evidence
"What we are seeing now is that because many more people have access to effective medical treatment for weight loss, the number of people experiencing this at one time is much larger, so we are just more aware." And the number of users is only growing
As an experimental triple receptor agonist that targets the GLP-1, GIP, and glucagon pathways, retatrutide has gotten a lot of attention for its possible use in studying glucose metabolism, weight control, and other metabolic processes
Feedback on the medications effects can help to decide whether a dosage adjustment is required